SRC and breast carcinoma: Additional studies in MCF-7/ADR cells by Fan et al. highlighted that Src induces epirubicin resistance in breast cancers by modulating the activity of the drug efflux pump p-glycoprotein (PgP), leading to increased expulsion of epirubicin from the cell [144].